In summary, these results provide new insights into the tumour‐promoting role of the SNHG16/miR‐497‐5p/PIM1 axis in DLBCL progression, which may improve our understanding of the pathogenesis of DLBCL and provide potential therapeutic targets. This evidence concerns the gene SNHG16 and diffuse large B-cell lymphoma.